Long-term results of cryopreserved arterial allograft reconstruction in infected prosthetic grafts and mycotic aneurysms of the abdominal aorta

Journal of Vascular Surgery

Volumn 34, Issue 4, 2001, Pages 616-622

  Lesèche, Guy ^a   Castier, Yves ^a   Petit, Marie Dominique ^a   Bertrand, Patrick ^a   Kitzis, Michel ^a   Mussot, Sacha ^a   Besnard, Mathieu ^a   Cerceau, Olivier ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; ALLOTRANSPLANTATION; AMPUTATION; ANEURYSM; AORTA ANEURYSM; ARTICLE; BLOOD VESSEL TRANSPLANTATION; CRYOPRESERVATION; FEMALE; FEMORAL ARTERY; FRANCE; GRAFT SURVIVAL; HUMAN; ILIAC ARTERY; INFECTION; LIFE TABLE; MALE; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PROSPECTIVE STUDY; REOPERATION; RISK FACTOR; STANDARD; STATISTICS; SURVIVAL; THORACIC AORTA; TIME; TRANSPLANTATION; TREATMENT OUTCOME; VASCULAR PATENCY;

ADULT; AGED; AGED, 80 AND OVER; AMPUTATION; ANEURYSM, INFECTED; ANTI-BACTERIAL AGENTS; AORTA, THORACIC; AORTIC ANEURYSM; BLOOD VESSEL PROSTHESIS IMPLANTATION; COMBINED MODALITY THERAPY; CRYOPRESERVATION; FEMALE; FEMORAL ARTERY; FRANCE; GRAFT SURVIVAL; HUMANS; ILIAC ARTERY; LIFE TABLES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; REOPERATION; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 0035487548     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2001.116107     Document Type: Article

References (34)

1. Curl G, Ricotta J. Total prosthetic graft excision and extra-anatomic bypass. In: Calligaro K, Veith F, editors. Management of infected arterial grafts. St Louis: Quality Medical Publishing; 1994. p. 82-94.
2. O'Hara PJ, Hertzer NR, Beven EG, Krajewski LP. Surgical management of infected abdominal aortic grafts: review of a 25-year experience. J Vasc Surg 1986;3:725-31.
3. Donaldson RM, Ross DM. Homograft aortic root replacement for complicated prosthetic valve endocarditis. Circulation 1984;70:178-81.
4. Zwischenberger JB, Shalaby TZ, Conti VR. Viable cryopreserved aortic homograft for aortic valve endocarditis and annular abscesses. Ann Thorac Surg 1989;48:365-9.
5. Leseche G, Penna C, Bouttier S, Joubert S, Andreassian B. Femorodistal bypass using cryopreserved venous allografts for limb salvage. Ann Vasc Surg 1997;11:230-6.
6. Castier Y, Leseche G, Palombi T, Petit MD, Cerceau O. Early experience with cryopreserved arterial allografts in below-knee revascularization for limb salvage. Am J Surg 1999;177:197-202.
7. Menawat SS, Gloviczki P, Serry RD, Cherry KJ, Bower TC, Hallett JW. Management of aortic graft-enteric fistulae. Eur J Vasc Endovasc Surg 1997;14 Suppl A:74-81.
8. Ricotta JJ, Faggioli GL, Stella A, Curl GR, Peer R, Upson J, et al. Total excision and extra-anatomic bypass for aortic graft infection. Am J Surg 1991;162:145-9.
9. Sharp WJ, Hoballah JJ, Mohan CR, Kresowik TF, Martinasevic M, Chalmers RT, et al. The management of the infected aortic prosthesis: a current decade of experience. J Vasc Surg 1994;19:844-50.
10. Yeager RA, Taylor LM Jr, Moneta GL, Edwards JM, Nicoloff AD, McConnell DB, et al. Improved results with conventional management of infrarenal aortic infection. J Vasc Surg 1999;30:76-83.
11. Seeger JM, Pretus HA, Welborn MB, Ozaki CK, Flynn TC, Huber TS. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vasc Surg 2000;32:451-9.
12. Quinones-Baldrich WJ, Hernandez JJ, Moore WS. Long-term results following surgical management of aortic graft infection. Arch Surg 1991;126:507-11.
13. Reilly LM, Ehrenfeld WK, Stoney RJ. Delayed aortic prosthetic reconstruction after removal of an infected graft. Am J Surg 1984;148:234-9.
14. Kieffer E, Bahnini A, Koskas F, Ruotolo C, Le Blevec D, Plissonnier D. In situ allograft replacement of infected infrarenal aortic prosthetic grafts: results in forty-three patients. J Vasc Surg 1993;17:349-55.
15. Koskas F, Goeau-Brissonniere O, Nicolas MH, Bacourt F, Kieffer E. Arteries from human beings are less infectible by Staphylococcus aureus than polytetrafluoroethylene in an aortic dog model. J Vasc Surg 1996;23:472-6.
16. Vogt PR, Pfammatter T, Schlumpf R, Genoni M, Kunzli A, Candinas D, et al. In situ repair of aortobronchial, aortoesophageal, and aortoenteric fistulas with cryopreserved aortic homografts. J Vasc Surg 1997;26:11-7.
17. Knosalla C, Weng Y, Yankah AC, Hofmeister J, Hetzer R. Using aortic allograft material to treat mycotic aneurysms of the thoracic aorta. Ann Thorac Surg 1996;61:1146-52.
18. Knosalla C, Goeau-Brissonniere O, Leflon V, Bruneval P, Eugene M, Pechere JC, et al. Treatment of vascular graft infection by in situ replacement with cryopreserved aortic allografts: an experimental study. J Vasc Surg 1998;27:689-98.
19. Kuestner LM, Reilly LM, Jicha DL, Ehrenfeld WK, Goldstone J, Stoney RJ. Secondary aortoenteric fistula: contemporary outcome with use of extraanatomic bypass and infected graft excision. J Vasc Surg 1995;21:184-95.
20. Clagett GP, Valentine RJ, Hagino RT. Autogenous aortoiliac/femoral reconstruction from superficial femoral-popliteal veins: feasibility and durability. J Vasc Surg 1997;25:255-66.
21. Nevelsteen A, Lacroix H, Suy R. Autogenous reconstruction with the lower extremity deep veins: an alternative treatment of prosthetic infection after reconstructive surgery for aortoiliac disease. J Vasc Surg 1995;22:129-34.
22. Towne JB, Seabrook GR, Bandyk D, Freischlag JA, Edmiston CE. In situ replacement of arterial prosthesis infected by bacterial biofilms: long-term follow-up. J Vasc Surg 1994;19:226-33.
23. Robinson JA, Johansen K. Aortic sepsis: is there a role for in situ graft reconstruction? J Vasc Surg 1991;13:677-82.
24. Hayes PD, Nasim A, London NJ, Sayers RD, Barrie WW, Bell PR, et al. In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998). J Vasc Surg 1999;30:92-8.
25. Szilagyi E, Rodriguez F, Smith R, Elliott J. Late fate of arterial allografts. Arch Surg 1970;101:721-33.
26. Vischjager M, Van Gulik TM, Van Marle J, Pfaffendorf M, Jacobs MJ. Function of cryopreserved arterial allografts under immunosuppressive protection with cyclosporine A. J Vasc Surg 1996;24:876-82.
27. Couvelard A, Leseche G, Scoazec JY, Groussard O. Human allograft vein failure: immunohistochemical arguments supporting the involvement of an immune-mediated mechanism. Hum Pathol 1995;26:1313-20.
28. Plissonnier D, Nochy D, Poncet P, Mandet C, Hinglais N, Bariety J, et al. Sequential immunological targeting of chronic experimental arterial allograft. Transplantation 1995;60:414-24.
29. Lehalle B, Geschier C, Fieve G, Stoltz JF. Early rupture and degeneration of cryopreserved arterial allografts. J Vasc Surg 1997;25:751-2.
30. Hunt CJ, Song YC, Bateson EA, Pegg DE. Fractures in cryopreserved arteries. Cryobiology 1994;31:506-15.
31. Allaire E, Guettier C, Bruneval P, Plissonnier D, Michel JB. Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg 1994;19:446-56.
32. Salomon RN, Friedman GB, Callow AD, Payne DD, Libby P. Cryopreserved aortic homografts contain viable smooth muscle cells capable of expressing transplantation antigens. J Thorac Cardiovasc Surg 1993;106:1173-80.
33. Schmitz-Rixen T, Megerman J, Colvin RB, Williams AM, Abbott WM. Immunosuppressive treatment of aortic allografts. J Vasc Surg 1988;7:82-92.
34. Kirk AD, Burkly LC, Batty DS, Baumgartner RE, Berning JD, Buchanan K, et al. Treatment with humanized monoclonal antibody against CD 154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999;5:686-93.